Signals Research Suite integrates workflows across biology, chemistry and materials new product development to arm scientists with better data, insights and outcomes Centrally installed and managed, the integrated suite covers the entire Make-Test-Decide lifecycle First solution released by Revvity under the new Revvity Signals Software brand WALTHAM, Mass. -- Today, Revvity, Inc. (NYSE: RVTY), announced the launch [...]

— Features a new software suite and more to revolutionize metal analysis for process control and research — Kleve, Germany – SPECTRO Analytical Instruments introduces the new SPECTROLAB S LAS02 high-end arc/spark OES metal analyzer for process control and research applications — designed to deliver the fastest possible measurements, greatest throughput, lowest limits of detection, longest [...]

SomaLogic’s 7,000-plex SomaScan® Platform will be used in clinical research, population health studies and nutrigenomics. BOULDER, Colo. -- SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain. As part of the agreement, Citogen will [...]

Integration of Polymer Standards Service Ltd. products results in the most complete and versatile GPC/SEC portfolio on the market SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced they will showcase their significantly expanded InfinityLab GPC/SEC Solution at the HPLC 2023 conference on June 18 – 22, 2023 in Düsseldorf, Germany. The Agilent InfinityLab GPC/SEC portfolio has become [...]

Collaboration will provide four German centres of excellence with Oxford Nanopore sequencing tools as part of a pilot to demonstrate increased rates of diagnosis and improved patient outcomes using long-read technology   Oxford Nanopore Technologies plc (Oxford Nanopore) today announced a research collaboration agreement with the ‘Clinical Long-read Genome Initiative’ (lonGER), a new national German programme [...]

The continued acquisition of specialized software tools will accelerate scientific discovery and improve clinical outcomes. BOSTON — Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it has acquired SoftGenetics, a bioinformatics software company that offers a range of advanced genetic analysis products for research, forensics, and healthcare applications. “With more than [...]

The partnership will improve access to clinical-grade genetically-modified induced pluripotent stem cells SEATTLE -- Pluristyx and panCELLa, a merged biotechnology company with offices in Seattle, WA and Toronto, Ontario, CA, are excited to announce their acceptance as an Industry Resource Partner (IRP) with the California Institute for Regenerative Medicine (CIRM). This partnership provides CIRM awardees [...]

MANCHESTER, England -- Proteintech announces its Manchester office has moved and expanded. The new site is based at Transmission, a brand-new building in Enterprise City, the fastest-growing industrial district of the city center. The new space has doubled the footprint of the Manchester site to accommodate the expansion of operations, sales, and marketing teams and [...]

Enables access to additional Latin America data to support equitable healthcare in cardiovascular R&D ZURICH, Switzerland -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the addition of one of Brazil’s leading cardiology centres, Hospital do Coração (HCor), to its Global Data Partner network, BCRQUEST.COM, to drive insights into [...]

Grand prize winner, Dr. Michael Khodadoust at Stanford University in Palo Alto, California, will use the Saphyr® system for research into CTCL (cutaneous t-cell lymphoma) Runner up prize winners are Dr. Afia Hasnain at The Hospital for Sick Children in Toronto, Canada, who will investigate ALL (acute lymphoblastic leukemia) samples using Children’s Oncology Group protocols, and Dr. Stefan Rentas at Duke University in Raleigh-Durham, North Carolina, who will study brain tumors and lymphomas An additional 12 prize [...]